FIELD: chemistry.
SUBSTANCE: invention relates to a new process for preparation of a formula (I) compound, wherein R1 and R2 are independently selected from hydrogen, C1-6alkyl, C3-7cycloalkyl, C3-6alkenyl or phenyl, at that, C1-6alkyl, cycloalkyl, C3-6alkenyl or phenyl may be optionally substituted and have halogen, hydroxyl, C1-6alkoxycarbonyl or phenyl as substituents, or R1 and R2 together with the carbon atom, to which they are attached, form C3-7cycloalkyl, comprising the following steps: a) protection of 3-aminopyrazole to form a formula (II) compound, where R3 represents C1-6alkyl, cycloalkyl or phenyl; b) 1-replacement of protected 3-aminopyrazole of formula (II) with a formula (III) compound and c) hydrolysis of protected 3-aminopyrazole of formula (III) in the presence of a base to form a formula (I) compound. The invention also relates to a new intermediate compound of formula II, wherein R1, R2 and R3 are methyl.
EFFECT: compounds prepared according to the invention can be used in synthesis and manufacture of compounds suitable for treatment of diseases or conditions associated with actin polymerization inhibition.
19 cl, 10 ex
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF BENZIMIDAZOL, COMPOSITIONS CONTAINING THEM, OBTAINING AND APPLICATION | 2004 |
|
RU2346938C2 |
HETEROARYL PYRROLIDINYL AND PIPERIDINYL KETONE DERIVATIVES | 2007 |
|
RU2479575C2 |
AMINOPYRAZOLOPYRIMIDINE COMPOUND USED AS INHIBITOR OF TYROSINE KINASE RECEPTOR OF NEUROTROPHIC FACTOR | 2017 |
|
RU2764523C2 |
SUBSTITUTED HETEROCYCLIC FUSED CYCLIC COMPOUND, METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL USE THEREOF | 2020 |
|
RU2815814C1 |
PYRAZOLAMINOPIRIMIDINE DERIVATIVES AS LEUCINE-REPEATING KINASE 2 (LRRK2) MODULATORS FOR TREATMENT OF PARKINSON DISEASE | 2013 |
|
RU2637948C2 |
PYRASOLE[3,4-b]PYRIDINE COMPOUNDS AND THEIR APPLICATION AS PHOSPHODIESTERASE INHIBITORS | 2003 |
|
RU2348633C2 |
SUBSTITUTED ARYLPYRAZOLES AS ANTIPARASITIC AGENTS | 2006 |
|
RU2381218C2 |
NOVEL PYRROLE COMPOUNDS, SYNTHESIS METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | 2014 |
|
RU2607788C2 |
NEW INDOLIZINE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2013 |
|
RU2646223C2 |
FLUORINE-18 AND CARBON-11 LABELED RADIOLIGANDS FOR POSITRON EMISSION TOMOGRAPHY (PET) IMAGING FOR LRRK2 | 2012 |
|
RU2650641C2 |
Authors
Dates
2017-06-07—Published
2013-12-20—Filed